Eli Lilly's Drug Suit Slammed As 'Anti-Competitive' Move

Eli Lilly and Co.'s lawsuit accusing a compounding pharmacy of unlawfully selling untested weight loss drugs should be tossed because the drugmaker didn't show its advertising was deceptive or harmful, the...

Already a subscriber? Click here to view full article